h-header

news

News from the world

02

Dec

Lonza sells Micro-Macinazione site in Switzerland to CDMO Microsize and Schedio Group

Microsize, a U.S.-based contract development and manufacturing organization (CDMO) specializing in particle size reduction and control technologies, has signed an agreement to acquire from Lonza its Micro-Macinazione (Mic Mac) dedicated micronization facility in Monteggio, Switzerland.

Under the deal for an undisclosed amount, Schedio Group — a Swiss-based provider of jet mills, isolators, spray dryers, and engineering services — is also investing with Microsize to strengthen and localize its operational base in Europe, according to the announcement. Both companies will invest in Mic Mac to boost its capabilities and hasten modernization...[PharmaManufacturing]

05

Dec

Farmaci essenziali sempre più scarsi: la Corte UE avverte sulle falle del sistema

Arriva dalla Corte dei Conti europea l’ultimo allarme relativo alla carenza dei medicinali, un...

04

Dec

Farmaci critici: l’Europa punta all’autonomia

Perché il Critical Medicines Act può ridurre la fragilità della filiera e l’eccessiva...

02

Dec

FDA Publishes Guidance on Current Good Manufacturing Practice for Medical Gases

The U.S. Food and Drug Administration has published the revised draft guidance for industry, Medical...

slider-banner

h-footer